<?xml version="1.0" encoding="UTF-8"?>
<p>The largest described group of pregnant women (43) with confirmed SARS-CoV-2 was presented by Breslin et al. [
 <xref rid="b16-medscimonit-26-e924725" ref-type="bibr">16</xref>]. These patients were hospitalized in 2 hospitals in New York from March 13 to 27, 2020. Fourteen women (32.6%) did not have any viral symptoms associated with COVID-19 at the time when SARS-CoV-2 infection was detected. Among them, 10 (71.4%) developed symptoms or signs of COVID-19 infection during or early after delivery. In 29 patients (67.4%) who had symptomatic COVID-19 infection, 3 women required hospitalization and antiviral treatment, and 1 woman received oxygen treatment after delivery due to her deteriorating condition. This study did not confirm SARS-CoV-2 cases in newborns. In summary, the authors stated that 37 (86%) women had a benign form of COVID-19, 4 (9.3%) had serious disease, and 2 (4.7%) developed critical disease [
 <xref rid="b16-medscimonit-26-e924725" ref-type="bibr">16</xref>].
</p>
